These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 7543051

  • 21. CD11a/CD18 (LFA-1) integrin engagement enhances biosynthesis of early cytokines by activated T cells.
    Fan ST, Brian AA, Lollo BA, Mackman N, Shen NL, Edgington TS.
    Cell Immunol; 1993 Apr 15; 148(1):48-59. PubMed ID: 8098668
    [Abstract] [Full Text] [Related]

  • 22. Beta 2-integrin-mediated signal up-regulates counterreceptor ICAM-1 expression on human monocytic cell line THP-1 through tyrosine phosphorylation.
    Yamada A, Hara A, Inoue M, Kamizono S, Higuchi T, Itoh K.
    Cell Immunol; 1997 May 25; 178(1):9-16. PubMed ID: 9184693
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Regulation of LFA-1 avidity in human B cells. Requirements for dephosphorylation events for high avidity ICAM-1 binding.
    Hedman H, Lundgren E.
    J Immunol; 1992 Oct 01; 149(7):2295-9. PubMed ID: 1356124
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S, Liu LN, Hosoi H, Dilling MB, Shikata T, Houghton PJ.
    Cancer Res; 2001 Apr 15; 61(8):3373-81. PubMed ID: 11309295
    [Abstract] [Full Text] [Related]

  • 27. CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulation.
    Pellat-Deceunynck C, Amiot M, Robillard N, Wijdenes J, Bataille R.
    Cancer Res; 1996 Apr 15; 56(8):1909-16. PubMed ID: 8620513
    [Abstract] [Full Text] [Related]

  • 28. Down's syndrome lymphoid cell lines exhibit increased adhesion due to the over-expression of lymphocyte function-associated antigen (LFA-1).
    Taylor GM, Haigh H, Williams A, D'Souza SW, Harris R.
    Immunology; 1988 Jul 15; 64(3):451-6. PubMed ID: 2842253
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin.
    Aagaard-Tillery KM, Jelinek DF.
    Cell Immunol; 1994 Jul 15; 156(2):493-507. PubMed ID: 7517796
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of cell cycle progression by a synthetic peptide corresponding to residues 65-79 of an HLA class II sequence: functional similarities but mechanistic differences with the immunosuppressive drug rapamycin.
    Boytim ML, Lyu SC, Jung R, Krensky AM, Clayberger C.
    J Immunol; 1998 Mar 01; 160(5):2215-22. PubMed ID: 9498760
    [Abstract] [Full Text] [Related]

  • 32. Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor.
    Dilling MB, Dias P, Shapiro DN, Germain GS, Johnson RK, Houghton PJ.
    Cancer Res; 1994 Feb 15; 54(4):903-7. PubMed ID: 7508822
    [Abstract] [Full Text] [Related]

  • 33. Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells.
    Metcalfe SM, Richards FM.
    Transplantation; 1990 Apr 15; 49(4):798-802. PubMed ID: 1691537
    [Abstract] [Full Text] [Related]

  • 34. Rapamycin (sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells.
    Javier AF, Bata-Csorgo Z, Ellis CN, Kang S, Voorhees JJ, Cooper KD.
    J Clin Invest; 1997 May 01; 99(9):2094-9. PubMed ID: 9151781
    [Abstract] [Full Text] [Related]

  • 35. Mimosine reversibly arrests cell cycle progression at the G1-S phase border.
    Watson PA, Hanauske-Abel HH, Flint A, Lalande M.
    Cytometry; 1991 May 01; 12(3):242-6. PubMed ID: 1903691
    [Abstract] [Full Text] [Related]

  • 36. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells.
    Marx SO, Jayaraman T, Go LO, Marks AR.
    Circ Res; 1995 Mar 01; 76(3):412-7. PubMed ID: 7532117
    [Abstract] [Full Text] [Related]

  • 37. Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts.
    Akselband Y, Harding MW, Nelson PA.
    Transplant Proc; 1991 Dec 01; 23(6):2833-6. PubMed ID: 1721292
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Hypersensitivity to rapamycin of BJAB B lymphoblastoid cells.
    Kay JE, Smith MC, Frost V, Morgan GY.
    Immunology; 1996 Mar 01; 87(3):390-5. PubMed ID: 8778023
    [Abstract] [Full Text] [Related]

  • 40. Selective in vivo growth of lymphocyte function- associated antigen-1-positive murine myeloma cells. Involvement of function-associated antigen-1-mediated homotypic cell-cell adhesion.
    Asosingh K, Vankerkhove V, Van Riet I, Van Camp B, Vanderkerken K.
    Exp Hematol; 2003 Jan 01; 31(1):48-55. PubMed ID: 12543106
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.